Our editorial approach
We curate material with an evidence-first mindset: primary registries, peer-reviewed literature, regulatory documents, and lived accounts are each treated with clear labels about their evidentiary weight. To illustrate how we separate sources in practice, you will find contextual links woven into explanatory prose throughout our pages; for services-oriented visitors we also outline offerings on our services page and link back to the site index from subpages to keep navigation straightforward.
We prioritize publicly verifiable sources: registry reports, clinical trial records, government health advisories and university publications. For example, we reference authoritative context such as the FDA's public pages or university summaries when describing regulatory timelines; reliable background on pharmacology is regularly cross-checked with entries like the relevant Wikipedia overview and institutional resources to avoid misstatements (Ibogaine — Wikipedia).
Contributors document each claim with a traceable source and a note on interpretation. When describing regulatory or safety information we consult primary government guidance (for example, clinical trial registration and advisory pages available through recognized public health sites) and academic literature hosted by universities for context (National Institutes of Health).